576 related articles for article (PubMed ID: 10657232)
1. Thioredoxin reductase.
Mustacich D; Powis G
Biochem J; 2000 Feb; 346 Pt 1(Pt 1):1-8. PubMed ID: 10657232
[TBL] [Abstract][Full Text] [Related]
2. Identification and conformer analysis of a novel redox-active motif, Pro-Ala-Ser-Cys-Cys-Ser, in Drosophila thioredoxin reductase by semiempirical molecular orbital calculation.
Kuwahara M; Tamura T; Kawamura K; Inagaki K
Biosci Biotechnol Biochem; 2011; 75(3):516-21. PubMed ID: 21389620
[TBL] [Abstract][Full Text] [Related]
3. Mammalian thioredoxin reductase: oxidation of the C-terminal cysteine/selenocysteine active site forms a thioselenide, and replacement of selenium with sulfur markedly reduces catalytic activity.
Lee SR; Bar-Noy S; Kwon J; Levine RL; Stadtman TC; Rhee SG
Proc Natl Acad Sci U S A; 2000 Mar; 97(6):2521-6. PubMed ID: 10688911
[TBL] [Abstract][Full Text] [Related]
4. Three-dimensional structure of a mammalian thioredoxin reductase: implications for mechanism and evolution of a selenocysteine-dependent enzyme.
Sandalova T; Zhong L; Lindqvist Y; Holmgren A; Schneider G
Proc Natl Acad Sci U S A; 2001 Aug; 98(17):9533-8. PubMed ID: 11481439
[TBL] [Abstract][Full Text] [Related]
5. The thioredoxin antioxidant system.
Lu J; Holmgren A
Free Radic Biol Med; 2014 Jan; 66():75-87. PubMed ID: 23899494
[TBL] [Abstract][Full Text] [Related]
6. Structure and mechanism of mammalian thioredoxin reductase: the active site is a redox-active selenolthiol/selenenylsulfide formed from the conserved cysteine-selenocysteine sequence.
Zhong L; Arnér ES; Holmgren A
Proc Natl Acad Sci U S A; 2000 May; 97(11):5854-9. PubMed ID: 10801974
[TBL] [Abstract][Full Text] [Related]
7. Antioxidant function of thioredoxin and glutaredoxin systems.
Holmgren A
Antioxid Redox Signal; 2000; 2(4):811-20. PubMed ID: 11213485
[TBL] [Abstract][Full Text] [Related]
8. Selenocysteine in mammalian thioredoxin reductase and application of ebselen as a therapeutic.
Ren X; Zou L; Lu J; Holmgren A
Free Radic Biol Med; 2018 Nov; 127():238-247. PubMed ID: 29807162
[TBL] [Abstract][Full Text] [Related]
9. Thioredoxin reductase as a pharmacological target.
Bjørklund G; Zou L; Wang J; Chasapis CT; Peana M
Pharmacol Res; 2021 Dec; 174():105854. PubMed ID: 34455077
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of thioredoxin and thioredoxin reductase by 4-hydroxy-2-nonenal in vitro and in vivo.
Fang J; Holmgren A
J Am Chem Soc; 2006 Feb; 128(6):1879-85. PubMed ID: 16464088
[TBL] [Abstract][Full Text] [Related]
11. Essential role of selenium in the catalytic activities of mammalian thioredoxin reductase revealed by characterization of recombinant enzymes with selenocysteine mutations.
Zhong L; Holmgren A
J Biol Chem; 2000 Jun; 275(24):18121-8. PubMed ID: 10849437
[TBL] [Abstract][Full Text] [Related]
12. Function of Glu-469' in the acid-base catalysis of thioredoxin reductase from Drosophila melanogaster.
Huang HH; Arscott LD; Ballou DP; Williams CH
Biochemistry; 2008 Dec; 47(48):12769-76. PubMed ID: 18991392
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of enzymatically active human cytosolic and mitochondrial thioredoxin reductase in HEK-293 cells. Effect on cell growth and differentiation.
Nalvarte I; Damdimopoulos AE; Nystöm C; Nordman T; Miranda-Vizuete A; Olsson JM; Eriksson L; Björnstedt M; Arnér ES; Spyrou G
J Biol Chem; 2004 Dec; 279(52):54510-7. PubMed ID: 15471857
[TBL] [Abstract][Full Text] [Related]
14. Active sites of thioredoxin reductases: why selenoproteins?
Gromer S; Johansson L; Bauer H; Arscott LD; Rauch S; Ballou DP; Williams CH; Schirmer RH; Arnér ES
Proc Natl Acad Sci U S A; 2003 Oct; 100(22):12618-23. PubMed ID: 14569031
[TBL] [Abstract][Full Text] [Related]
15. A diterpenoid derivate compound targets selenocysteine of thioredoxin reductases and induces Bax/Bak-independent apoptosis.
Liu J; Mu C; Yue W; Li J; Ma B; Zhao L; Liu L; Chen Q; Yan C; Liu H; Hao X; Zhu Y
Free Radic Biol Med; 2013 Oct; 63():485-94. PubMed ID: 23732520
[TBL] [Abstract][Full Text] [Related]
16. Thioredoxin reductase is irreversibly modified by curcumin: a novel molecular mechanism for its anticancer activity.
Fang J; Lu J; Holmgren A
J Biol Chem; 2005 Jul; 280(26):25284-90. PubMed ID: 15879598
[TBL] [Abstract][Full Text] [Related]
17. A mechanistic investigation of the C-terminal redox motif of thioredoxin reductase from Plasmodium falciparum.
Snider GW; Dustin CM; Ruggles EL; Hondal RJ
Biochemistry; 2014 Jan; 53(3):601-9. PubMed ID: 24400600
[TBL] [Abstract][Full Text] [Related]
18. Small molecule inhibitors of mammalian thioredoxin reductase.
Cai W; Zhang L; Song Y; Wang B; Zhang B; Cui X; Hu G; Liu Y; Wu J; Fang J
Free Radic Biol Med; 2012 Jan; 52(2):257-65. PubMed ID: 22064364
[TBL] [Abstract][Full Text] [Related]
19. High-level expression in Escherichia coli of selenocysteine-containing rat thioredoxin reductase utilizing gene fusions with engineered bacterial-type SECIS elements and co-expression with the selA, selB and selC genes.
Arnér ES; Sarioglu H; Lottspeich F; Holmgren A; Böck A
J Mol Biol; 1999 Oct; 292(5):1003-16. PubMed ID: 10512699
[TBL] [Abstract][Full Text] [Related]
20. Thioredoxin system in cell death progression.
Lu J; Holmgren A
Antioxid Redox Signal; 2012 Dec; 17(12):1738-47. PubMed ID: 22530689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
